Forsythoside F ne D3 Vandetanib was the first drug

Vandetanib was the first drug to be approved by FDA (April 2011) for treatment of late-stage (metastatic) medullary thyroid cancer in adult patients who are ineligible for surgery

Gossypol binds to Bcl-xL protein and Bcl-2 protein with Kis of 0

3-d]pyridazin-7-yl)oxy)methyl)-N-methylpicolinamide

ent-crizotinib

CAS Number: 528-48-3

Forsythoside F ne D3 Vandetanib was the first drugForsythoside F (Arenarioside) is a xanthine oxidase inhibitor and possesses antihyperuricemic effects in vivo. Product information CAS Number: 94130 58 2 Molecular Weight: 756. 70 Formula: C34H44O19 Chemical Name: (2R,3R,4R,5R,6R) 6 [2 (3,4 dihydroxyphenyl)ethoxy] 5 hydroxy 4 {[(2S,3R,4R,5R,6S) 3,4,5 trihydroxy 6 methyloxan 2 yl]oxy} 2 ({[(2S,3R,4S,5R) 3,4,5 trihydroxyoxan 2 yl]oxy}methyl)oxan 3 yl (2E) 3 (3,4 dihydroxyphenyl)prop 2 enoate Smiles: